Showing results (481-490 of 641) with videos related to

Sort By:
Pageof 65
Clinical Pharmacology and Therapeutics|January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 UpdateMaud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Nature Communications|February 13, 2016
A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiologyEric A Hungate, Sapana R Vora, Eric R Gamazon, et al.
Clinical Pharmacology and Therapeutics|March 26, 2021
Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase HypersensitivityYiwei Liu, Wenjian Yang, Colton A Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Childhood Acute Lymphoblastic Leukemia: Progress Through CollaborationChing-Hon Pui, Jun J Yang, Stephen P Hunger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemiaDeepa Bhojwani, Noah D Sabin, Deqing Pei, et al.
The Journal of Clinical Investigation|November 9, 2020
Pharmacogenomics of intracellular methotrexate polyglutamates in patients' leukemia cells in vivoElixabet Lopez-Lopez, Robert J Autry, Colton Smith, et al.
Frontiers in Pediatrics|November 17, 2022
Energy cost of walking in obese survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime CohortMatthew D Wogksch, Emily R Finch, Vikki G Nolan, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 18, 2011
Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populationsNeha Mehta, Alan S Wayne, Youn H Kim, et al.
Pageof 65